4-2824745-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001122681.2(SH3BP2):​c.357+15G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0437 in 1,573,094 control chromosomes in the GnomAD database, including 1,784 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.049 ( 223 hom., cov: 34)
Exomes 𝑓: 0.043 ( 1561 hom. )

Consequence

SH3BP2
NM_001122681.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.520

Publications

2 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 4-2824745-G-T is Benign according to our data. Variant chr4-2824745-G-T is described in ClinVar as Benign. ClinVar VariationId is 258895.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.357+15G>T intron_variant Intron 4 of 12 ENST00000503393.8 NP_001116153.1 P78314-1A0A384N6E5
SH3BP2NM_001145856.2 linkc.528+15G>T intron_variant Intron 4 of 12 NP_001139328.1 P78314-4
SH3BP2NM_001145855.2 linkc.441+15G>T intron_variant Intron 4 of 12 NP_001139327.1 P78314-3
SH3BP2NM_003023.4 linkc.357+15G>T intron_variant Intron 4 of 12 NP_003014.3 P78314-1A0A384N6E5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.357+15G>T intron_variant Intron 4 of 12 1 NM_001122681.2 ENSP00000422168.3 P78314-1

Frequencies

GnomAD3 genomes
AF:
0.0487
AC:
7412
AN:
152162
Hom.:
223
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0727
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.0518
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.0272
Gnomad SAS
AF:
0.0912
Gnomad FIN
AF:
0.00424
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0384
Gnomad OTH
AF:
0.0483
GnomAD2 exomes
AF:
0.0456
AC:
11360
AN:
249006
AF XY:
0.0475
show subpopulations
Gnomad AFR exome
AF:
0.0742
Gnomad AMR exome
AF:
0.0481
Gnomad ASJ exome
AF:
0.0473
Gnomad EAS exome
AF:
0.0289
Gnomad FIN exome
AF:
0.00422
Gnomad NFE exome
AF:
0.0384
Gnomad OTH exome
AF:
0.0457
GnomAD4 exome
AF:
0.0431
AC:
61295
AN:
1420814
Hom.:
1561
Cov.:
26
AF XY:
0.0446
AC XY:
31613
AN XY:
709408
show subpopulations
African (AFR)
AF:
0.0803
AC:
2628
AN:
32712
American (AMR)
AF:
0.0479
AC:
2138
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.0481
AC:
1245
AN:
25908
East Asian (EAS)
AF:
0.0287
AC:
1134
AN:
39510
South Asian (SAS)
AF:
0.0912
AC:
7796
AN:
85514
European-Finnish (FIN)
AF:
0.00540
AC:
282
AN:
52222
Middle Eastern (MID)
AF:
0.0803
AC:
456
AN:
5682
European-Non Finnish (NFE)
AF:
0.0399
AC:
42893
AN:
1075556
Other (OTH)
AF:
0.0461
AC:
2723
AN:
59058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3075
6150
9224
12299
15374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1716
3432
5148
6864
8580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0487
AC:
7415
AN:
152280
Hom.:
223
Cov.:
34
AF XY:
0.0492
AC XY:
3662
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0726
AC:
3017
AN:
41546
American (AMR)
AF:
0.0518
AC:
792
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3472
East Asian (EAS)
AF:
0.0272
AC:
141
AN:
5176
South Asian (SAS)
AF:
0.0915
AC:
442
AN:
4832
European-Finnish (FIN)
AF:
0.00424
AC:
45
AN:
10624
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0384
AC:
2612
AN:
68006
Other (OTH)
AF:
0.0478
AC:
101
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
369
738
1108
1477
1846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0207
Hom.:
8
Bravo
AF:
0.0520
Asia WGS
AF:
0.0520
AC:
184
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fibrous dysplasia of jaw Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
7.1
DANN
Benign
0.60
PhyloP100
-0.52
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62620003; hg19: chr4-2826472; API